NPM1 and chronic myelogenous leukemia, BCR-ABL1 positive: Moreover, recently the Imiquimod derivative EAPB503 has shown to inhibit growth and to induce apoptosis in chronic myeloid leukemia cells [20], and in AML cells expressing mutant nucleophosmin 1 [21].